About Daktari Diagnostics
Daktari Diagnostics is a company based in Boston (United States) founded in 2008. Daktari Diagnostics has raised $73.42 million across 15 funding rounds from investors including NIH, HHS and NIAID. The company has 23 employees as of December 31, 2022. Daktari Diagnostics operates in a competitive market with competitors including Souzhou Ribo Life Science, Senzo, Hememics Biotechnologies, PathoQuest and Quantalife, among others.
- Headquarter Boston, United States
- Employees 23 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Daktari Diagnostics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$73.42 M (USD)
in 15 rounds
-
Latest Funding Round
$221.65 K (USD), Grant
May 01, 2017
-
Investors
NIH
& 11 more
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Daktari Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Daktari Diagnostics
Daktari Diagnostics has successfully raised a total of $73.42M across 15 strategic funding rounds. The most recent funding activity was a Grant round of $221.65 thousand completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Grant — $221,653
-
First Round
First Round
(04 Sep 2009)
- Investors Count 12
Investors in Daktari Diagnostics
Daktari Diagnostics has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and NIAID.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are provided by an angel network to Boston-based companies.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Daktari Diagnostics
Financial Statements - Daktari Diagnostics
Daktari Diagnostics Comparisons
Competitors of Daktari Diagnostics
Daktari Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, Senzo, Hememics Biotechnologies, PathoQuest and Quantalife, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Sequencing-based platform for microorganism detection in patients is developed.
|
Latest news on Daktari Diagnostics
Frequently Asked Questions about Daktari Diagnostics
Daktari Diagnostics was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Daktari Diagnostics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Daktari Diagnostics is a funded company, having raised a total of $73.42M across 15 funding rounds to date. The company's 1st funding round was a Grant of $649.57K, raised on Sep 04, 2009.
As of Dec 31, 2022, the latest employee count at Daktari Diagnostics is 23.
Daktari Diagnostics was founded in 2008 in Boston, United States, within the diagnostics sector. A portable point-of-care diagnostic platform with wireless connectivity and a cloud-based data management system is provided. Offerings include Daktari Virology for HCV and HIV detection, Daktari InSight for connecting systems to customers, and Daktari Sickle Cell for identifying infants with sickle cell disease. A partnership with Merck Co for Hepatitis C was announced.
Daktari Diagnostics's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.